• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿病与 I 组代谢型谷氨酸受体。

Huntington's disease and Group I metabotropic glutamate receptors.

机构信息

Departamento de Bioquimica e Imunologia, ICB, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.

出版信息

Mol Neurobiol. 2011 Feb;43(1):1-11. doi: 10.1007/s12035-010-8153-1. Epub 2010 Dec 9.

DOI:10.1007/s12035-010-8153-1
PMID:21153060
Abstract

Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder characterized by involuntary body movement, cognitive impairment and psychiatric disturbance. A polyglutamine expansion in the amino-terminal region of the huntingtin (htt) protein is the genetic cause of HD. Htt protein interacts with a wide variety of proteins, and htt mutation causes cell signaling alterations in various neurotransmitter systems, including dopaminergic, glutamatergic, and cannabinoid systems, as well as trophic factor systems. This review will overview recent findings concerning htt-promoted alterations in cell signaling that involve different neurotransmitters and trophic factor systems, especially involving mGluR1/5, as glutamate plays a crucial role in neuronal cell death. The neuronal cell death that takes place in the striatum and cortex of HD patients is the most important factor underlying HD progression. Metabotropic glutamate receptors (mGluR1 and mGluR5) have a very controversial role in neuronal cell death and it is not clear whether mGluR1/5 activation either protects or exacerbates neuronal death. Thus, understanding how mutant htt protein affects glutamatergic receptor signaling will be essential to further establish a role for glutamate receptors in HD and develop therapeutic strategies to treat HD.

摘要

亨廷顿病(HD)是一种常染色体显性神经退行性疾病,其特征是不自主的身体运动、认知障碍和精神障碍。亨廷顿蛋白(htt)氨基末端区域的多聚谷氨酰胺扩展是 HD 的遗传原因。htt 蛋白与多种蛋白质相互作用,htt 突变导致各种神经递质系统(包括多巴胺能、谷氨酸能和大麻素系统以及营养因子系统)中的细胞信号改变。本综述将概述最近关于 htt 促进涉及不同神经递质和营养因子系统的细胞信号改变的发现,特别是涉及 mGluR1/5 的发现,因为谷氨酸在神经元细胞死亡中起着至关重要的作用。HD 患者纹状体和皮质中发生的神经元细胞死亡是 HD 进展的最重要因素。代谢型谷氨酸受体(mGluR1 和 mGluR5)在神经元细胞死亡中具有非常有争议的作用,并且不清楚 mGluR1/5 的激活是保护还是加剧神经元死亡。因此,了解突变 htt 蛋白如何影响谷氨酸能受体信号对于进一步确定谷氨酸受体在 HD 中的作用以及开发治疗 HD 的治疗策略至关重要。

相似文献

1
Huntington's disease and Group I metabotropic glutamate receptors.亨廷顿病与 I 组代谢型谷氨酸受体。
Mol Neurobiol. 2011 Feb;43(1):1-11. doi: 10.1007/s12035-010-8153-1. Epub 2010 Dec 9.
2
Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease.在亨廷顿舞蹈症的YAC小鼠模型中,全长突变型亨廷顿蛋白对于纹状体神经元Ca2+信号改变和细胞凋亡是必需的。
Neurobiol Dis. 2008 Jul;31(1):80-8. doi: 10.1016/j.nbd.2008.03.010. Epub 2008 Apr 16.
3
The mGluR5 positive allosteric modulator, CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington's disease.mGluR5 正变构调节剂 CDPPB 改善亨廷顿病小鼠模型的病理和表型特征。
Neurobiol Dis. 2015 Jan;73:163-73. doi: 10.1016/j.nbd.2014.08.021. Epub 2014 Aug 24.
4
Metabotropic glutamate receptor 5 as a potential therapeutic target in Huntington's disease.代谢型谷氨酸受体 5 作为亨廷顿病的潜在治疗靶点。
Expert Opin Ther Targets. 2014 Nov;18(11):1293-304. doi: 10.1517/14728222.2014.948419. Epub 2014 Aug 14.
5
Effects of mutant huntingtin on mGluR5-mediated dual signaling pathways: implications for therapeutic interventions.突变型亨廷顿蛋白对 mGluR5 介导的双信号通路的影响:对治疗干预的启示。
Cell Mol Neurobiol. 2010 Oct;30(7):1107-15. doi: 10.1007/s10571-010-9543-7. Epub 2010 Jul 20.
6
Metabotropic glutamate receptor 5 positive allosteric modulators are neuroprotective in a mouse model of Huntington's disease.代谢型谷氨酸受体 5 正变构调节剂在亨廷顿病的小鼠模型中具有神经保护作用。
Br J Pharmacol. 2013 Jun;169(4):909-21. doi: 10.1111/bph.12164.
7
Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease.特定的半胱天冬酶相互作用和放大参与亨廷顿舞蹈病中的选择性神经元易损性。
Cell Death Differ. 2004 Apr;11(4):424-38. doi: 10.1038/sj.cdd.4401358.
8
Towards a transgenic model of Huntington's disease in a non-human primate.迈向非人类灵长类动物亨廷顿舞蹈症转基因模型
Nature. 2008 Jun 12;453(7197):921-4. doi: 10.1038/nature06975. Epub 2008 May 18.
9
Hunting for excitement: NMDA receptors in Huntington's disease.探寻兴奋之源:亨廷顿舞蹈病中的NMDA受体
Neuron. 2002 Mar 14;33(6):841-2. doi: 10.1016/s0896-6273(02)00631-1.
10
Lack of interleukin-1 type 1 receptor enhances the accumulation of mutant huntingtin in the striatum and exacerbates the neurological phenotypes of Huntington's disease mice.缺乏白细胞介素 1 型受体可增强纹状体中突变 huntingtin 的积累,并加重亨廷顿病小鼠的神经表型。
Mol Brain. 2010 Nov 2;3:33. doi: 10.1186/1756-6606-3-33.

引用本文的文献

1
Nuclear ERK1/2 signaling potentiation enhances neuroprotection and cognition via Importinα1/KPNA2.核 ERK1/2 信号增强通过 Importinα1/KPNA2 增强神经保护和认知。
EMBO Mol Med. 2023 Nov 8;15(11):e15984. doi: 10.15252/emmm.202215984. Epub 2023 Oct 4.
2
Metabotropic Glutamate Receptor 5 Antagonism Reduces Pathology and Differentially Improves Symptoms in Male and Female Heterozygous zQ175 Huntington's Mice.代谢型谷氨酸受体5拮抗剂可减轻雄性和雌性杂合子zQ175亨廷顿病小鼠的病理变化并不同程度改善症状。
Front Mol Neurosci. 2022 Feb 2;15:801757. doi: 10.3389/fnmol.2022.801757. eCollection 2022.
3
Astrocytes in Neural Circuits: Key Factors in Synaptic Regulation and Potential Targets for Neurodevelopmental Disorders.

本文引用的文献

1
Quantitative relationships between huntingtin levels, polyglutamine length, inclusion body formation, and neuronal death provide novel insight into huntington's disease molecular pathogenesis.亨廷顿病分子发病机制的新见解来自于对亨廷顿蛋白水平、多聚谷氨酰胺长度、包含体形成和神经元死亡之间定量关系的研究。
J Neurosci. 2010 Aug 4;30(31):10541-50. doi: 10.1523/JNEUROSCI.0146-10.2010.
2
Group I metabotropic glutamate receptor signalling and its implication in neurological disease.I 型代谢型谷氨酸受体信号及其在神经疾病中的意义。
CNS Neurol Disord Drug Targets. 2010 Nov;9(5):574-95. doi: 10.2174/187152710793361612.
3
Fatty acid amide hydrolase and monoacylglycerol lipase inhibitors produce anti-allodynic effects in mice through distinct cannabinoid receptor mechanisms.
神经回路中的星形胶质细胞:突触调节的关键因素及神经发育障碍的潜在靶点
Front Mol Neurosci. 2021 Sep 29;14:729273. doi: 10.3389/fnmol.2021.729273. eCollection 2021.
4
Oxytocin Prevents the Development of 3-NP-Induced Anxiety and Depression in Male and Female Rats: Possible Interaction of OXTR and mGluR2.催产素可预防雄性和雌性大鼠中 3-NP 诱导的焦虑和抑郁的发展:OXTR 和 mGluR2 的可能相互作用。
Cell Mol Neurobiol. 2022 May;42(4):1105-1123. doi: 10.1007/s10571-020-01003-0. Epub 2020 Nov 17.
5
Transcriptome analysis identified long non-coding RNAs involved in the adaption of yak to high-altitude environments.转录组分析确定了参与牦牛适应高海拔环境的长链非编码RNA。
R Soc Open Sci. 2020 Sep 23;7(9):200625. doi: 10.1098/rsos.200625. eCollection 2020 Sep.
6
The Renin-Angiotensin System in Huntington's Disease: Villain or Hero?亨廷顿舞蹈病中的肾素-血管紧张素系统:反派还是英雄?
Protein Pept Lett. 2020;27(6):456-462. doi: 10.2174/0929866527666200110154523.
7
Elevated Type 1 Metabotropic Glutamate Receptor Availability in a Mouse Model of Huntington's Disease: a Longitudinal PET Study.亨廷顿病小鼠模型中 1 型代谢型谷氨酸受体可用性升高:一项纵向 PET 研究。
Mol Neurobiol. 2020 Apr;57(4):2038-2047. doi: 10.1007/s12035-019-01866-5. Epub 2020 Jan 8.
8
Regenerative glutamate release in the hippocampus of Rett syndrome model mice.Rett 综合征模型小鼠海马中的再生谷氨酸释放。
PLoS One. 2018 Sep 26;13(9):e0202802. doi: 10.1371/journal.pone.0202802. eCollection 2018.
9
Noninvasive Relative Quantification of [C]ABP688 PET Imaging in Mice Versus an Input Function Measured Over an Arteriovenous Shunt.小鼠中[C]ABP688正电子发射断层显像(PET)成像的非侵入性相对定量与通过动静脉分流测量的输入函数的比较
Front Neurol. 2018 Jun 29;9:516. doi: 10.3389/fneur.2018.00516. eCollection 2018.
10
Role of Dynein Axonemal Heavy Chain 6 Gene Expression as a Possible Biomarker for Huntington's Disease: a Translational Study.动力蛋白轴索重链 6 基因表达作为亨廷顿病的一种可能生物标志物的作用:一项转化研究。
J Mol Neurosci. 2017 Dec;63(3-4):342-348. doi: 10.1007/s12031-017-0984-z. Epub 2017 Oct 10.
脂肪酸酰胺水解酶和单酰甘油脂肪酶抑制剂通过不同的大麻素受体机制在小鼠中产生抗痛觉过敏作用。
J Pain. 2010 Dec;11(12):1420-8. doi: 10.1016/j.jpain.2010.04.001. Epub 2010 Jun 16.
4
Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders.大麻素-多巴胺相互作用在中枢神经系统疾病的发病机制和治疗中的作用。
CNS Neurosci Ther. 2010 Jun;16(3):e72-91. doi: 10.1111/j.1755-5949.2010.00144.x. Epub 2010 Apr 12.
5
Metabotropic glutamate receptor-mediated cell signaling pathways are altered in a mouse model of Huntington's disease.代谢型谷氨酸受体介导的细胞信号通路在亨廷顿病的小鼠模型中发生改变。
J Neurosci. 2010 Jan 6;30(1):316-24. doi: 10.1523/JNEUROSCI.4974-09.2010.
6
Dopamine D2 receptor stimulation potentiates PolyQ-Huntingtin-induced mouse striatal neuron dysfunctions via Rho/ROCK-II activation.多巴胺 D2 受体刺激通过 Rho/ROCK-II 激活增强 PolyQ-亨廷顿蛋白诱导的小鼠纹状体神经元功能障碍。
PLoS One. 2009 Dec 15;4(12):e8287. doi: 10.1371/journal.pone.0008287.
7
Mitochondria, oxidative metabolism and cell death in stroke.线粒体、氧化代谢与中风中的细胞死亡
Biochim Biophys Acta. 2010 Jan;1802(1):80-91. doi: 10.1016/j.bbadis.2009.09.003. Epub 2009 Sep 12.
8
BDNF regulates BIM expression levels in 3-nitropropionic acid-treated cortical neurons.脑源性神经营养因子调节3-硝基丙酸处理的皮质神经元中BIM的表达水平。
Neurobiol Dis. 2009 Sep;35(3):448-56. doi: 10.1016/j.nbd.2009.06.006. Epub 2009 Jun 23.
9
Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease.在亨廷顿舞蹈症转基因小鼠模型中,CB1受体和内源性大麻素水平的改变先于运动症状出现。
Neuroscience. 2009 Sep 29;163(1):456-65. doi: 10.1016/j.neuroscience.2009.06.014. Epub 2009 Jun 10.
10
Metabotropic glutamate receptors in the tripartite synapse as a target for new psychotropic drugs.三方突触中的代谢型谷氨酸受体作为新型精神药物的靶点。
Neurochem Int. 2009 Jul-Aug;55(1-3):85-97. doi: 10.1016/j.neuint.2009.02.019. Epub 2009 Mar 9.